Navigation Links
Peregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
Date:5/13/2008

- Two New Studies Provide Further Evidence that PS Plays a Critical Role in

Some Viral Infections - - Peregrine's Anti-PS Antibody Bavituximab is Currently Being Assessed in a

Clinical Trial in HCV Patients Co-Infected with HIV -

TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today reported that two independent studies recently published in the journal Science (1,2) highlight the critical importance of the cellular membrane lipid phosphatidylserine (PS) in the ability of some enveloped viruses to infect cells. Peregrine is a leader in the development of anti-PS therapies. Its lead anti-PS antibody bavituximab has successfully completed two Phase I trials in HCV patients and is currently in a clinical trial in patients co-infected with HCV and HIV. Bavituximab is also being assessed in a Phase I single agent cancer study and in Phase II cancer trials in combination with chemotherapy.

"These two excellent studies from independent groups of researchers exemplify the growing interest in the scientific community in the role of PS in viral infectivity and important aspects of immunity," said Steven W. King, president and CEO of Peregrine. "In particular, we believe that the paper discussing the vaccinia virus(1) independently confirms some of the key mechanisms underlying the anti-viral potential of our anti-PS antibodies. It shows that PS is essential to the ability of the virus to infect cells, and that when PS is blocked, infection cannot occur. The study also discusses how PS helps the virus to evade
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
2. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
3. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
4. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
5. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
6. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
8. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
9. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
10. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
11. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 Cayenne Medical, Inc., a ... the soft tissue reconstruction segment, announced the worldwide ... surgeries involving the shoulder and extremities. The SureLock ... inserter-controlled deployment method. The unique delivery eliminates manual ... pull-out, or anchor displacement (also commonly know as ...
(Date:7/10/2014)... Toronto, Canada (PRWEB) July 10, 2014 ... often present in very low abundance and are ... quite challenging and time-consuming. , Join presenters Dr. ... Laboratories, and Dr. John Anders, Head of Quality ... mass spectrometer-based approach that can speed detection and ...
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... San Francisco, CA (PRWEB) July 10, 2014 ... a family closer together. The Archer Family purchased ... information contained within DNA, but ended up with a ... surprising discoveries contained within the family members’ DNA genuinely ... family had decided to search deeper into genetic history ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5
... agreements: One with an international livestock semen distributor who will invest ... business; and another agreement with an engineering firm to move it ... , , ... /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX: TSX), a biotechnology company, ...
... Surface tension isn,t a very powerful force, but it ... turns out, nanowires. Nanowires are so tiny that a ... billionths of a meter. Because of their small size, surface ... limiting their usefulness. This is a problem because the wires ...
... NEW YORK and MONTREAL , July 21 /PRNewswire-FirstCall/ - ... the company has entered into talks with a new possible Chinese partner. , ... " China is one of the ... situations on the planet" said Don Saunders President and CEO of ...
Cached Biology Technology:Microbix Signs $2 Million Partnership Agreement For its Livestock Semen Sexing Technology (LumiSort(TM)) 2Microbix Signs $2 Million Partnership Agreement For its Livestock Semen Sexing Technology (LumiSort(TM)) 3Microbix Signs $2 Million Partnership Agreement For its Livestock Semen Sexing Technology (LumiSort(TM)) 4Engineering researchers simplify process to make world's tiniest wires 2BioSpec Global Solutions Inc. Enters into talks with possible Chinese partner 2
(Date:7/10/2014)... other major cities in New Mexico, nearly every public ... rather than precious potable water supplies. Across the U.S. ... golf courses receive treated effluent. Reusing the effluent increases ... courses and homeowners alike fertilize their lawns during the ... A New Mexico State University turfgrass expert has a ...
(Date:7/10/2014)... YORK , June 27, 2014  Pomerantz ... Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) ... filed in United States District Court, Middle District ... is on behalf of a class consisting of ... acquired Provectus securities between December 17, 2013 and ...
(Date:7/10/2014)... SPRINGS, Florida , July 1, 2014 ... wallets pave way for convenience and improved security: NXT-ID, Inc. ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) ... is pleased to announce that the second series of 30 ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
... caused more than $193 million in hospital-based medical care ... problems such as asthma and pneumonia that are triggered ... Corporation study. Researchers estimate that exposure to excessive ... emergency room visits and hospital admissions over the study ...
... paper that describes a file format used by scientists ... citations in the ISI Web of Knowledge, an online ... The Systems Biology Markup Language (SBML) is designed to ... between different computer software packages, allowing the models to ...
... In one of the most comprehensive global studies of marine ... University of Rhode Island and other institutions has found that ... success of marine reserves. "We make a big mistake ... and other aquatic organisms," said Richard Pollnac, URI professor of ...
Cached Biology News:Study finds dirty air in California causes millions worth of medical care each year 2Study finds dirty air in California causes millions worth of medical care each year 3After 5 years, free systems biology markup language has proven popular 2After 5 years, free systems biology markup language has proven popular 3Scientists find community involvement, not only enforcement, drives success of marine reserves 2
... higher plant to be fully sequenced and ... organism for gene expression research in higher ... derived from the ATH1 v.5 database of ... from the Arabidopsis MPSS database at the ...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
... ShortCut RNase III, used with its manganese-containing ... a heterogeneous mix of short (1825 bp) ... in mammalian cells. 1.3 units (1 l) ... convert 1 g of dsRNA into siRNA ...
...
Biology Products: